First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study
- PMID: 40036636
- DOI: 10.1093/bjd/ljaf063
First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study
Conflict of interest statement
Conflicts of interest: S.H.M. reports employment by Merck. C.K. reports employment by Health Data Insight CIC and NHS England. M.K. reports employment by and stock ownership in Merck. E.B. reports employment by and stock ownership in Merck. P.V. reports employment by Merck at the time of the study. J.N. and Z.C.V. declare no conflicts of interest.
Grants and funding
LinkOut - more resources
Full Text Sources
